Table 2.
Author (Date) | Study Design | Muscle; Type of Investigation | Measure of Muscle Strength | Sample (n) | Results | Comments |
---|---|---|---|---|---|---|
Adeniyi (2004)55 | Single case report | Iliopsoas, quadriceps, and TA; EMG recordings (type of electrode used not clearly indicated) | Clinical assessment of muscle strength (measures not reported); participant report of difficulty rising from chair | HD=1 | Brief, small, abundant polyphasic potentials characteristic of myopathy | EMG studies suggestive of neuropathic and myopathic changes |
Albertazzi (1980)46 | Case-control |
|
Unclear | HD=20 Con=20 |
|
Results support myopathy as a possible cause of muscular weakness. |
Bautista (1983)56 | Case series | Deltoid; type of electrodes used not indicated | Clinical evaluation demonstrated proximal muscle weakness (measures not reported) | HD=8 | Normal interference pattern | Normal EMG changes |
Blank (1986)61 | Case series | BB; EMG using needle electrode | Implicit suggestions of muscle weakness based on prior published reports of common complaints of muscle weakness in people on haemodialysis | HD=9 |
|
Observations suggest neuropathic origin in 4 participants and myopathic origin in 5 participants. |
Fahal (1997)37 | Case-control |
|
|
HD=19 Con=27 |
|
|
Floyd (1974)15 | Case-control | Quadriceps and deltoid; EMG recordings using needle electrode | Clinical assessment of strength (measures not reported) | HD=10 Con=7 |
|
Results suggest skeletal muscle weakness of neuropathic and myopathic origin. |
Gambaro (1987)29 | Case-control | ABD and EDB (authors have not clearly indicated the muscles explored); EMG using needle electrode to study motor unit action potential following stimulation of ulnar and CPN | Symptoms of peripheral nervous system involvement, including muscle weakness, present in 55% of participants on HD (measures not reported) | HD=31 Con=30 |
|
|
Harrison (2006)59 | Case series | 1st dorsal interrosseous and vastus lateralis; EMG recordings using surface electrode | 30-second chair-stand test (12±0.8); no comparison with Con | HD=25 | EMG frequency recorded prior to HD was generally low and abnormal. |
|
Isaacs (1969)63 | Case series |
|
Participant complaints of muscle weakness by the participants on HD associated with functional limitations (measures not reported) | HD=15 |
|
|
Johansen (2005)38 | Case-control | TA; CMAP before and after exercise protocol; start @ 10% MVC and ↑ 10% every 2 min. End-of-exercise MVC and CMAP obtained | MVC using dynamometry (p=0.04) | HD=33 Con=12 |
CMAP was lower at baseline and did not change significantly after the exercise (p=0.003). |
|
Konishi (1981)30 | Case-control | EDC; SFEMG using needle electrode to obtain fibre-density and jitter values | Implicit suggestions of muscle weakness based on presence of peripheral neuropathy in people on HD as per prior published reports | HD=19 Con=20 |
|
|
Lazaro (1980)16 | Case series | Variable proximal muscles | Clinical assessment of strength (measures not reported), participant reports of gait abnormalities such as waddling gait or difficulty walking, difficulty rising from the chair | HD=4 | Bizarre high-frequency discharges in one participant; all participants demonstrated short-amplitude and short-duration polyphasic potentials in all muscles examined. | Changes attributed to uremic myopathy |
Rochhi (1986)48 | Case-control |
|
Possible presence of weakness based on presence of myopathy and neuropathy as per prior published reports | HD=20 Comparison with normal values for the laboratory |
8 HD participants showed significant shift of the peak frequency of the spectral array toward values higher than Con group. |
Results support myopathy as cause of muscle weakness. |
Sobh (1992)62 | Case series | BB representative of proximal muscle, and APB representative of distal muscle; EMG study including duration of MUAP amplitude, and interference pattern | Possible presence of weakness based on presence of neuropathy as per prior published reports | HD=6 |
|
Results indicate distal involvement and neuropathic pattern. |
Tilki (2009)25 | Case-control |
|
Possible presence of weakness based on presence of neuropathy as per prior published reports | HD=30 Comparison with normal values for the laboratory |
|
|
APB=abductor pollicis brevis; ABD=abductor digiti minimi; BB=biceps brachii; Con=control group; CPN=common peroneal nerve; CMAP=compound muscle action potential; CRF=chronic renal failure; EDB=extensor digitorum brevis; EDC=extensor digitorum communis; EMG=electromyography; E-C coupling=excitation–contraction coupling; FFT=fast Fourier transform; HD=haemodialysis group; Hz=hertz; MAPD=mean action-potential duration; MAPA=mean action-potential amplitude; MUAP=motor-unit action potential; MVC=maximum voluntary contraction; NCS=nerve-conduction studies; QEMG=quantitative electromyography; SFEMG=single-fibre electromyography; TA=tibialis anterior; UE=upper extremity